Christine Lindenboom | Senior Vice President, Investor Relations & Corporate Communications |
John Maraganore | Chief Executive Officer |
Tolga Tanguler | Chief Commercial Officer |
Akshay Vaishnaw | President, R&D |
Jeff Poulton | Chief Financial Officer |
Yvonne Greenstreet | President & Chief Operating Officer |
Tazeen Ahmad | Bank of America |
Maury Raycroft | Jefferies |
Alethia Young | Cantor Fitzgerald |
Sonya Bhatia | Goldman Sachs |
David Lebowitz | Morgan Stanley |
Gena Wang | Barclays |
Paul Matteis | Stifel |
Ritu Baral | Cowen |
Jon Lim | UBS |
Thank you for standing by and welcome to the Alnylam Pharmaceuticals First Quarter 2021 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder today's program is being recorded. And now I'd like to introduce your host for today's program, Christine Lindenboom, Senior Vice President of Investor Relations and Corporate Communications.